Clinical Trial Update: A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing SHR-3167 to Insulin Degludec in adults with Type 2 diabetes, sponsored by Jiangsu HengRui Medicine Co., Ltd., currently liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR-3167
• insulin degludec (insulin degludec)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: ACTIVE_NOT_RECRUITING